Odendaal H J, Steyn D W, Norman K, Kirsten G F, Smith J, Theron G B
Department of Obstetrics and Gynaecology, MRC Unit for Perinatal Mortality, Tygerborg Hospital, W. Cape.
S Afr Med J. 1995 Oct;85(10 Suppl):1071-6.
To ascertain the change in perinatal mortality (PNM) rate over a period of 10 years in 1001 patients with severe pre-eclampsia.
Patients with severe pre-eclampsia before a gestational age of 34 weeks were managed expectantly. Initial treatment consisted of the administration of magnesium sulphate to prevent convulsions and dihydralazine to reduce blood pressure. Methyldopa alone or in combination with other oral antihypertensive drugs was started soon after admission. In order to prevent fetal death from abruptio placentae, the fetal heart rate was monitored at least four times per day. Patients were delivered either at 34 weeks' gestation or when fetal or maternal indications for immediate delivery were present. The 10-year study was divided into four successive time periods and the PNM rate was calculated separately for each of these time periods.
Perinatal survival was low if patients were delivered before or at 26 weeks' gestation but improved rapidly if delivered thereafter. There were only 33 intrauterine deaths of babies who weighed 1000 g or more. The majority of these deaths were due to abruptio placentae which had occurred prior to admission to hospital. The PNM rate for babies of 1000 g or more decreased from 61 in the first time phase and 83 in the second to 19 in the last. The overall PNM rate during the 10-year study was 62.
Improved knowledge about the management of patients with severe pre-eclampsia in early pregnancy resulted in a decline in the PNM rate. Although the exact cause of this reduction towards the end of the study is not known, several factors probably played a role. They are expectant management with a little gain in the gestational age, better fetal monitoring before and during labour, earlier detection of fetal distress, earlier referral to the tertiary hospital and improved neonatal care.
确定1001例重度子痫前期患者在10年期间围产期死亡率(PNM)的变化。
对孕34周前的重度子痫前期患者进行期待治疗。初始治疗包括静脉滴注硫酸镁以预防抽搐,以及使用肼屈嗪降低血压。入院后不久开始单独使用甲基多巴或与其他口服降压药联合使用。为预防胎盘早剥导致的胎儿死亡,每天至少监测4次胎儿心率。患者在孕34周时分娩,或出现胎儿或母亲需要立即分娩的指征时分娩。这项为期10年的研究分为四个连续时间段,分别计算每个时间段的PNM率。
如果患者在孕26周前或孕26周时分娩,围产期存活率较低,但此后分娩则迅速改善。体重1000克或以上的婴儿仅有33例宫内死亡。这些死亡大多是由于入院前发生的胎盘早剥。体重1000克或以上婴儿的PNM率从第一阶段的61例和第二阶段的83例降至最后阶段的19例。10年研究期间的总体PNM率为62例。
对妊娠早期重度子痫前期患者管理知识的提高导致PNM率下降。虽然研究接近尾声时这种下降的确切原因尚不清楚,但可能有几个因素起了作用。这些因素包括期待治疗使孕周略有增加、分娩前和分娩期间更好的胎儿监测、更早发现胎儿窘迫、更早转诊至三级医院以及改善新生儿护理。